ETV Bharat / business

US Has No Alternative To Indian Generic Drugs: Natco Pharma CEO Rajiv Nannapaneni

He said it is not possible to produce them in the US, as the raw materials of generic medicines are available in India and China.

Hyderabad: Rajiv Nannapaneni, vice-chairman and CEO of Natco Pharma, believes that there is no threat to the Indian pharma sector from the recent trade tariffs imposed by the US, as it consumes 92% Indian generic drugs.

"There is a trend around the world not to depend on other countries for self-reliance. America is doing this now. But many countries have been trying in this direction for a long time," he told ETV Bharat.

He said there is less impact on the pharma sector from trade tariffs compared to other sectors due to its exemption. "Our co

See Full Page